Imidazopyridine derivatives as cannabinoid receptor ligands

Details for Australian Patent Application No. 2006278191 (hide)

Owner Glaxo Group Limited

Inventors Eatherton, Andrew John; Mitchell, William Leonard; Naylor, Alan; Swarbrick, Martin; Page, Lee William; Sweeting, Jennifer Anne; Giblin, Gerard Martin Paul

Agent Davies Collison Cave

Pub. Number AU-A-2006278191

PCT Pub. Number WO2007/017237

Priority 0516380.3 09.08.05 GB; 0524324.1 29.11.05 GB

Filing date 7 August 2006

Wipo publication date 15 February 2007

International Classifications

C07D 471/02 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/5377 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/017237 Priority application(s): WO2007/017237

19 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006278210-Method for controlling phytopathogenic organisms

2006278183-Method for carrying out the selective evolution of proteins in vitro